- Home
- TOPS vs OCX Comparison
TOPS vs OCX Comparison
Compare TOPS & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- OCX
- Stock Information
- Founded
- TOPS 2000
- OCX 2009
- Country
- TOPS Greece
- OCX United States
- Employees
- TOPS N/A
- OCX N/A
- Industry
- TOPS Marine Transportation
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TOPS Consumer Discretionary
- OCX Health Care
- Exchange
- TOPS Nasdaq
- OCX Nasdaq
- Market Cap
- TOPS 31.1M
- OCX 38.7M
- IPO Year
- TOPS 2004
- OCX N/A
- Fundamental
- Price
- TOPS $6.73
- OCX $2.37
- Analyst Decision
- TOPS
- OCX Buy
- Analyst Count
- TOPS 0
- OCX 3
- Target Price
- TOPS N/A
- OCX $4.42
- AVG Volume (30 Days)
- TOPS 14.6K
- OCX 112.2K
- Earning Date
- TOPS 01-14-2025
- OCX 11-12-2024
- Dividend Yield
- TOPS N/A
- OCX N/A
- EPS Growth
- TOPS N/A
- OCX N/A
- EPS
- TOPS N/A
- OCX N/A
- Revenue
- TOPS $83,870,000.00
- OCX $709,000.00
- Revenue This Year
- TOPS $7.10
- OCX N/A
- Revenue Next Year
- TOPS $6.54
- OCX $106.34
- P/E Ratio
- TOPS N/A
- OCX N/A
- Revenue Growth
- TOPS 1.10
- OCX N/A
- 52 Week Low
- TOPS $5.30
- OCX $1.97
- 52 Week High
- TOPS $15.91
- OCX $3.57
- Technical
- Relative Strength Index (RSI)
- TOPS 53.31
- OCX 49.32
- Support Level
- TOPS $5.75
- OCX $2.23
- Resistance Level
- TOPS $6.21
- OCX $2.69
- Average True Range (ATR)
- TOPS 0.39
- OCX 0.17
- MACD
- TOPS 0.11
- OCX 0.04
- Stochastic Oscillator
- TOPS 100.00
- OCX 55.56
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.